Global Rules on Foreign Direct Investment
Cross-border acquisitions and investments increasingly trigger foreign direct investment (FDI) screening requirements.
Proposed COVID-19 legislation would pause merger activity
Representatives wrote to US House leadership requesting that the next stimulus bill include a moratorium on transactions that do not involve firms that are truly failing.
Global antitrust and competition trends for 2020
We are living through the most dynamic period in antitrust and competition policy for decades – with pressure for change coming from different directions and likely to generate concrete proposals and political controversy in 2020, plus the global COVID-19 (coronavirus) pandemic adding unprecedented complexity and uncertainty.
US: DOJ continues to greenlight coronavirus medical collaborations
The US DOJ again announces it won’t challenge an ongoing collaboration among competitors and government agencies to provide essential COVID-19 healthcare supplies.
An ounce of prevention: Minimizing US antitrust risk when evaluating labor practices
COVID-19 has forced many companies to evaluate, and implement cuts to their workforces, reductions in pay, benefits, and hours, or both.
Cooperation amid COVID-19: Medical supply collaboration won’t face US antitrust scrutiny
The US DOJ announced in a business review letter its intent not to challenge an ongoing collaboration between numerous healthcare companies
Credit for compliance: Achieving the benefits of a robust antitrust compliance program
COVID-19 (coronavirus) is naturally the focus of everyone’s attention currently given the unprecedented scale of the crisis.
COVID-19: Implications from an antitrust and competition law perspective
The current COVID-19 (coronavirus) crisis sweeping the world is having a hugely disruptive impact on society and business, and our first thoughts and best wishes are with our clients, colleagues and their families who are facing this unprecedented public health challenge.